Brinker Capital Investments, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brinker Capital Investments, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2022$1,022,000
+115.6%
16,162
+81.0%
0.02%
+128.6%
Q4 2021$474,000
-61.0%
8,929
-51.1%
0.01%
-63.2%
Q3 2021$1,216,0000.0%18,2520.0%0.02%
+18.8%
Q2 2021$1,216,000
-22.5%
18,252
+29.0%
0.02%
-33.3%
Q1 2021$1,570,000
+26066.7%
14,146
+25160.7%
0.02%
Q4 2019$6,000560.00%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders